Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Open-Label Study of ARD-0403 in Testosterone Deficient Men

ClinicalTrials.gov ID: NCT00562731

Public ClinicalTrials.gov record NCT00562731. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Open-Label Follow-on Study for Long-Term Safety and Efficacy of Testosterone Cream, in Testosterone Deficinet Men Completing Study ARD-0403-004

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Male hypogonadism, a disorder associated with testosterone deficiency, is frequently seen in clinical practice and has significant effects on patient well-being. The purpose of this study is to investigate the efficacy and safety of ARD-0403 as a testosterone replacement therapy in testosterone deficient men.

Study identification

NCT ID
NCT00562731
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ardana Bioscience Ltd
Industry
Enrollment
150 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2007 (Type not available)
Primary completion
Not listed
Completion
Jun 2008 (Estimated)
Last update posted
Apr 1, 2008

2007 – 2008

United States locations

U.S. sites
12
U.S. states
10
U.S. cities
12
Facility City State ZIP Site status
Medical Affiliated Research Center, Inc Huntsville Alabama 35801 —
Stanford University Stanford California 94305-5826 —
Harbor-UCLA Medical Center Torrance California 90502 —
Northwestern University Chicago Illinois 60611-3008 —
Johns Hopkins University Baltimore Maryland 21287 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Duke University Medical Center Durham North Carolina 27706 —
Oregon Health and Science University Portland Oregon 97239 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Baylor College of Medicine Houston Texas 77030 —
dgd Research San Antonio Texas 78229-4801 —
VA Puget Sound Health Care System Seattle Washington 98493 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00562731, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2008 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00562731 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →